Exact Mass: 463.04111480000006
Exact Mass Matches: 463.04111480000006
Found 67 metabolites which its exact mass value is equals to given mass value 463.04111480000006,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Adenylsuccinic acid
Adenylsuccinic acid, also known as adenylosuccinate, succinyladenosine or aspartyl adenylate, belongs to the class of organic compounds known as purine ribonucleoside monophosphates. These are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Adenylsuccinic acid is found in all living organisms, ranging from bacteria to plants to animals. Adenylsuccinic acid is an important intermediate in the de novo purine biosynthesis pathway. Specifically, adenylsuccinic acid is an intermediate in the interconversion of purine nucleotides inosine monophosphate (IMP) and adenosine monophosphate (AMP). The enzyme adenylosuccinate synthase carries out the reaction by the addition of aspartate to IMP. This reaction requires the input of energy from a phosphoanhydride bond in the form of guanosine triphosphate (GTP). Adenylsuccinic acid is a substrate least one other important metabolic reaction in purine biosynthesis. In particular, adenylsuccinic acid can be converted into fumaric acid through its interaction with the enzyme known as adenylosuccinate lyase (or adenylosuccinase). Adenylosuccinate lyase deficiency, is a rare autosomal recessive metabolic disorder characterized by the appearance of succinylaminoimidazolecarboxamide riboside (SAICA riboside) and adenylsuccinic acid in cerebrospinal fluid and urine (PMID: 8412002). Adenylosuccinate lyase deficiency presents with varying degrees of psychomotor retardation, autism, muscle wasting, and epilepsy. The exact cause of the symptoms is unknown, but possibilities include not enough purine nucleotide synthesis for cell replication, malfunctioning of the purine nucleotide cycle, and a buildup of substrates to toxic levels. Adenylsuccinic acid is a substrate of the enzyme adenylosuccinase [EC 4.3.2.2] in purine metabolism pathway. The accumulation of adenylsuccinic acid in body fluids occurs due to a deficiency of adenylosuccinase. (KEGG; PMID 8412002) [HMDB] D018377 - Neurotransmitter Agents > D018846 - Excitatory Amino Acids KEIO_ID A037; [MS2] KO008839 KEIO_ID A037; [MS3] KO008840 KEIO_ID A037
L 735821
D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators
[(3S)-1-Azabicyclo[2.2.2]octan-3-yl] 2-hydroxy-2-(4-iodophenyl)-2-phenylacetate
C21H22INO3 (463.06443720000004)
Adenylosuccinic acid
O1-Benzoyl-2-(4-{[3-chloro-5-(trifluoromethyl)-2-pyridyl]methoxy}phenyl)ethanehydroximamide
C22H17ClF3N3O3 (463.09104780000007)
Chondritinsulfate
C13H21NO15S (463.06318760000005)
2-METHOXYETHYL 2-(5-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY]-2-NITROPHENOXY)PROPANOATE
C19H17ClF3NO7 (463.06455980000004)
N-(5-chloro-2-methylphenyl)-4-[(5-chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide
5-[4-benzoyl-2,3-bis[(6-diazonio-5-oxidonaphthalen-1-yl)sulfonyloxy]phenoxy]sulfonyl-2-diazonionaphthalen-1-olate
ammonium 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-hexadecafluorononan-1-oate
4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]benzeneethanamine hydrochloride
C18H23ClINO3 (463.04111480000006)
Thiazolidine, 2-(3-bromo-4-methoxyphenyl)-3-(1-naphthalenylsulfonyl)- (9CI)
2-[N-(2-cyanoethyl)-4-[(2,6-dichloro-4-nitrophenyl)azo]-3-methylanilino]ethyl acetate
C20H19Cl2N5O4 (463.08140340000006)
[2-[(2-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate
C26H16ClF2NO3 (463.0786720000001)
[2-[(3-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate
C26H16ClF2NO3 (463.0786720000001)
[2-[(4-chlorophenyl)carbamoyl]-4-(2,4-difluorophenyl)phenyl] benzoate
C26H16ClF2NO3 (463.0786720000001)
AZOMETHIN-H MONOSODIUM SALT HYDRATE
C17H14NNaO9S2 (463.00076740000003)
Thiazolidine, 2-(5-bromo-2-methoxyphenyl)-3-(1-naphthalenylsulfonyl)- (9CI)
N-(4-chloro-2-methylphenyl)-4-[(4-chloro-2-methylphenyl)azo]-3-hydroxynaphthalene-2-carboxamide
Azomethine-H monosodium salt hydrate
C17H14NNaO9S2 (463.00076740000003)
2-(3-BroMo-biphenyl-3-yl)-4,6-diphenyl-[1,3,5]triazine
2-(3-bromobiphenyl-4-yl)-4,6-diphenyl-1,3,5-triazine
2-(3,4-Dihydroxyphenyl)-3-(beta-D-glucopyranuronosyloxy)-5,7-dihydroxy-1-benzopyrylium
C21H19O12 (463.08764740000004)
beta-D-Mannopyranosyl azide 3,4,6-triacetate 2-(1,1,1-trifluoromethanesulfonate)
CHONDROITIN SULFATE SHARK CARTILAGE(RG)
C13H21NO15S (463.06318760000005)
N-[7-(3-Aminophenyl)-5-methoxy-1,3-benzoxazol-2-YL]-2,5-dichlorobenzenesulfonamide
C20H15Cl2N3O4S (463.01602900000006)
Aspartyl adenylate
D018377 - Neurotransmitter Agents > D018846 - Excitatory Amino Acids
1-S-[2-(4-hydroxy-1H-indol-3-yl)-N-(sulfooxy)ethanimidoyl]-1-thio-beta-D-glucopyranose
2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxo-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-3-olate
C21H19O12- (463.08764740000004)
(4S,4aS,5aS,6S,12aR)-2-carbamoyl-7-chloro-4-(dimethylazaniumyl)-6,10,12a-trihydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-1,11-diolate
3-[4-[[[4-chloro-3-(trifluoromethyl)anilino]-oxomethyl]amino]phenoxy]-N-methylbenzamide
C22H17ClF3N3O3 (463.09104780000007)
3-[[4-(1,1,1,3,3,3-Hexafluoro-2-hydroxypropan-2-yl)phenyl]sulfamoyl]-2-thiophenecarboxylic acid methyl ester
9-(3-bromo-4-hydroxyphenyl)-10-phenyl-3,4,5,6,7,9-hexahydro-2H-acridine-1,8-dione
C25H22BrNO3 (463.07829620000007)
N-(1,3-benzodioxol-5-yl)-2-[[4-(4-methoxyphenyl)-6-(trifluoromethyl)-2-pyrimidinyl]thio]acetamide
C21H16F3N3O4S (463.08135720000007)
5-Acetamido-4-hydroxy-3-(phenyldiazenyl)naphthalene-2,7-disulfonate
4-amino-N-[2-[[5-bromo-2-[(2-fluorophenyl)methoxy]phenyl]methylamino]ethyl]-1,2,5-oxadiazole-3-carboxamide
(5R)-3-[bis(4-bromophenyl)methoxy]-8-methyl-8-azabicyclo[3.2.1]octane
C21H23Br2NO (463.01462680000003)
3,4,5-Trihydroxy-6-[2-hydroxy-5-(3,5,7-trihydroxychromenylium-2-yl)phenoxy]oxane-2-carboxylic acid
C21H19O12+ (463.08764740000004)
6-[2-(3,4-Dihydroxyphenyl)-3,5-dihydroxychromenylium-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
C21H19O12+ (463.08764740000004)
delphinidin 3-O-beta-D-galactoside(1-)
C21H19O12- (463.08764740000004)
(E)-3-(2,4-dichlorophenyl)-N-[(3R)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]prop-2-enamide
D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators
N(6)-(1,2-dicarboxyethyl)-AMP
The N(6)-(1,2-dicarboxyethyl) derivative of adenosine 5-monophosphate.
myricitrin(1-)
C21H19O12 (463.08764740000004)
A flavonoid oxoanion that is the conjugate base of myricitrin arising from selective deprotonation of the 7-hydroxy group; major species at pH 7.3.
quercetin 3-O-beta-D-glucopyranoside(1-)
C21H19O12 (463.08764740000004)
A flavonoid oxoanion resulting from the deprotonation of the hydroxy group at position 7 of the flavone moiety of quercetin. The major species at pH 7.3.
4-hydroxyglucobrassicin(1-)
An indolylmethylglucosinolate that is the conjugate base of 4-hydroxyglucobrassicin.
6-({2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(sulfooxy)oxan-4-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
C13H21NO15S (463.06318760000005)
(2s,3s,4s,5r,6r)-6-{[(2r,3r,4r,5r,6r)-2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(sulfooxy)oxan-4-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid
C13H21NO15S (463.06318760000005)